Skip to main content
BKKT
NYSE Crypto Assets

Bakkt Q2 2026: $80.8M GAAP Net Income Driven by $98.5M Non-Cash Transchem Warrant Gain; TTV Guidance of ~$2.5B for Full Year

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$7.253
Mkt Cap
$341.284M
52W Low
$6.75
52W High
$49.79
52W Position info
7.4% above low
Off High info
85% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

BKKT is trading near its 52-week low of $6.75 (7.4% above the low).

Summary

Bakkt's Q2 2026 GAAP net income of $80.8 million was entirely from a non-cash Transchem warrant gain; core operations posted an $11.8 million adjusted EBITDA loss on collapsing revenue. The company guided to ~$2.5 billion in full-year TTV and Q4 2026 product launches, but faces significant execution risk.


Key Events · Earnings and Guidance · BKKT

  • GAAP Net Income Driven by Non-Cash Gain

    Q2 2026 GAAP net income of $80.8 million ($1.96 basic / $1.94 diluted EPS) was entirely driven by a $98.5 million non-cash gain from the change in fair value of Transchem warrants. Excluding this and other non-cash items, adjusted EBITDA loss was $11.8 million.

  • Revenue Collapse Continues

    Total revenue fell 70% year-over-year to $170.1 million, reflecting previously disclosed client transitions and industry-wide softness in digital asset trading volumes. Crypto costs and execution fees of $169.3 million nearly offset all revenue.

  • Full-Year TTV Guidance of ~$2.5 Billion

    Management expects Total Transacting Volume of approximately $2.5 billion for full-year 2026, implying a massive ramp from the $410.0 million recorded in H1 2026. This assumes successful client integrations and activations in the second half.

  • Product Launches Targeted for Q4 2026

    Bakkt Agent Embedded Finance is available for partner integration now, with initial co-branded card programs and Neobank-as-a-Service offerings targeted for Q4 2026. Monthly Active Users are expected to reach ~25,000 by December 2026.


Analysis · BKKT · Crypto Assets

Bakkt reported a GAAP net income of $80.8 million, but this was entirely driven by a $98.5 million non-cash gain from the fair value remeasurement of its Transchem warrants — not from operations. The core business remains deeply unprofitable, with an adjusted EBITDA loss of $11.8 million and a 70% revenue collapse to $170.1 million, reflecting client losses and weak crypto trading volumes. The company provided full-year TTV guidance of approximately $2.5 billion, implying a massive ramp in the second half, and expects to launch co-branded card programs and a Neobank-as-a-Service in Q4 2026. Cash stood at $50.7 million with no long-term debt, but the company has been aggressively tapping equity markets, raising $69.6 million in H1 2026 through a registered direct offering and ATM sales. The Transchem warrant position, now valued at $107.9 million on the balance sheet, is a non-cash mark-to-market asset that could swing sharply with the underlying share price. Investors should focus on the adjusted EBITDA loss and the execution risk around the ambitious second-half TTV and product launch targets.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BKKT was trading at $7.25 on NYSE in the Crypto Assets sector, with a market capitalization of approximately $341.3M. The 52-week trading range was $6.75 to $49.79. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BKKT - Latest Insights

BKKT
Nov 09, 2026, 8:48 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.56
Real-time Price: $3.42 info
Change: -$1.14 (-25%) info
Market Cap: $152.528M info
BKKT
Nov 09, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.54
Real-time Price: $3.42 info
Change: -$1.12 (-25%) info
Market Cap: $152.528M info
BKKT
Nov 09, 2026, 4:33 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.46
Real-time Price: $3.42 info
Change: -$1.04 (-23%) info
Market Cap: $152.528M info
BKKT
Nov 09, 2026, 4:31 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.67
Real-time Price: $3.42 info
Change: -$1.25 (-27%) info
Market Cap: $152.528M info
BKKT
Sep 09, 2026, 10:06 AM EDT
Source: BayStreet
Importance Score:
7
Price at Filing: $8.66
Real-time Price: $3.42 info
Change: -$5.24 (-61%) info
Market Cap: $152.528M info